Regeneron Pharmaceuticals, Inc.
2017 Q1 - 2025 Q4 (35 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 5,471 | 0.0% | 7,089 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 3,437 | 0.0% | 6,112 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 3,048 | 0.0% | 5,805 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 4,693 | 0.0% | 7,400 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 5,573 | 0.0% | 7,824 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 3,399 | 0.0% | 3,234 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 3,493 | 0.0% | 3,323 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 2,341 | 0.0% | 2,558 | 3/31/2024 |
| 2023 Q4 | 8/15/2024 | 1,266 | 0.0% | 1,441 | 12/31/2023 |
| 2023 Q3 | 8/15/2024 | 1,058 | 0.0% | 1,286 | 9/30/2023 |
| 2023 Q2 | 8/15/2024 | 1,118 | 0.0% | 1,556 | 6/30/2023 |
| 2023 Q1 | 8/15/2024 | 2,868 | 0.0% | 3,490 | 3/31/2023 |
| 2022 Q4 | 8/15/2024 | 1,947 | 0.0% | 2,699 | 12/31/2022 |
| 2022 Q3 | 8/15/2024 | 1,859 | 0.0% | 2,699 | 9/30/2022 |
| 2022 Q2 | 8/15/2024 | 1,599 | 0.0% | 2,705 | 6/30/2022 |
| 2022 Q1 | 8/15/2024 | 811 | 0.0% | 1,161 | 3/31/2022 |
| 2021 Q4 | 8/30/2024 | 523 | 0.0% | 829 | 12/31/2021 |
| 2021 Q3 | 8/30/2024 | 412 | 0.0% | 681 | 9/30/2021 |
| 2021 Q2 | 8/30/2024 | 528 | 0.0% | 946 | 6/30/2021 |
| 2021 Q1 | 8/30/2024 | 863 | 0.0% | 1,824 | 3/31/2021 |
| 2020 Q4 | 8/30/2024 | 3,286 | 0.0% | 6,798 | 12/31/2020 |
| 2020 Q3 | 8/30/2024 | 480 | 0.0% | 858 | 9/30/2020 |
| 2020 Q2 | 8/30/2024 | 427 | 0.0% | 684 | 6/30/2020 |
| 2020 Q1 | 8/30/2024 | 33 | 0.0% | 68 | 3/31/2020 |
| 2019 Q4 | 8/30/2024 | 16 | 0.0% | 43 | 12/31/2019 |
| 2019 Q3 | 8/30/2024 | 12 | 0.0% | 43 | 9/30/2019 |
| 2019 Q2 | 8/30/2024 | 13 | 0.0% | 43 | 6/30/2019 |
| 2019 Q1 | 8/30/2024 | 43 | 0.0% | 105 | 3/31/2019 |
| 2018 Q4 | 8/30/2024 | 66 | 0.0% | 176 | 12/31/2018 |
| 2018 Q3 | 8/30/2024 | 71 | 0.0% | 176 | 9/30/2018 |
| 2018 Q2 | 8/30/2024 | 67 | 0.0% | 193 | 6/30/2018 |
| 2018 Q1 | 8/30/2024 | 15 | 0.0% | 43 | 3/31/2018 |
| 2017 Q3 | 8/30/2024 | 13 | 0.0% | 30 | 9/30/2017 |
| 2017 Q2 | 8/30/2024 | 15 | 0.0% | 30 | 6/30/2017 |
| 2017 Q1 | 8/30/2024 | 92 | 0.0% | 238 | 3/31/2017 |